首页> 外文OA文献 >Comparative Study between Triple Therapy (Peginterferon /Ribavirin/Sofosbuvir) and Dual Therapy (Simeprevir /Sofosbuvir) in Treatment of Chronic HCV Patients

【2h】

Comparative Study between Triple Therapy (Peginterferon /Ribavirin/Sofosbuvir) and Dual Therapy (Simeprevir /Sofosbuvir) in Treatment of Chronic HCV Patients

机译：三重疗法（Peginterferon / Ribavirin / Sofosbuvir）与双治疗（Simeprevir / Sofosbuvir）治疗慢性HCV患者的比较研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Adel Awaad; No’omaan El Garem; Tamer ELeraky; Hosam El Dahrouty;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Dual treatment with sofosbuvir plus ribavirin is as effective as triple therapy with pegylated interferon plus sofosbuvir plus ribavirin in predominant genotype 3 patients with chronic hepatitis C [J] . Satsangi Sandeep, Mehta Manu, Duseja Ajay, Journal of gastroenterology and hepatology . 2017,第4期

机译：用Sofosbuvir Plus利巴韦林的双重治疗与Pegylated干扰素加上Sofosbuvir Plus利巴韦林的三重疗法有效3患者慢性丙型肝炎患者
2. Treatment of Chronic HCV With Sofosbuvir (SOF) and Simeprevir (SMV) in Patients With Cirrhosis and Contraindications to Peginterferon (PEGINF) and Ribavirin (RBV) [J] . Shiffman Mitchell, James Amy, Long April, The American Journal of Gastroenterology . 2014,第Suppla2期

机译：索非布韦（SOF）和西美普韦（SMV）在肝硬化和聚乙二醇干扰素（PEGINF）和利巴韦林（RBV）的禁忌症患者中治疗慢性HCV
3. Sofosbuvir plus Peginterferon plus Ribavirin for 12 Weeks in Genotype 3 HCV Infected Patients and Treatment-Experienced Cirrhotic Patients with Genotype 2 HCV Who Did Not Achieve SVR after 16 or 24 Weeks of Sofosbuvir plus Ribavirin [J] . Agarwal Kosh, Schultz Michael, Pianko Stephen, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2016,第S1期

机译：Sofosbuvir Plus Peginterferon Plus利韦利林在基因型中为12周，3个HCV感染患者和治疗经验丰富的肝硬化患者2 HCV在Sofosbuvir Plus利巴韦林的16或24周后没有达到SVR
4. Predictability of Sustained Virological Response (SVR) in Patients with HCV/HIV Co-infection During Combination Therapy With Peginterferon Alfa-2A (40KD) (PEGASYS~R) Plus Ribavirin (COPEGUS~R) in the APRICOT Trial [C] . M. Rodriguez Torres, F.J. Torriani, E. Lissen International AIDS Conference . 2004

机译：HCV / HIV与Peginterferon Alfa-2a（40KD）（Pegasys〜R）加上利韦韦林（Copegus〜R）在杏试验期间HCV / HIV CONOMENT患者持续病毒学反应（SVR）的可预测性
5. The role of emotional repression in chronic back pain: A study of chronic back pain patients undergoing psychodynamically oriented group psychotherapy as treatment for their pain. [D] . Hawkins, Jeffrey R. 2003

机译：情绪抑制在慢性背痛中的作用：一项针对接受心理动力学定向集体心理治疗的慢性背痛患者的研究。
6. Real-World Experiences with the Combination Treatment of Ledipasvir plus Sofosbuvir for 12 Weeks in HCV Genotype 1-Infected Japanese Patients: Achievement of a Sustained Virological Response in Previous Users of Peginterferon plus Ribavirin with HCV NS3/4A Inhibitors [O] . Tatsuo Kanda, Shin Yasui, Masato Nakamura, 2017

机译：在丙型肝炎病毒基因型1感染的日本患者中联合应用Ledipasvir和Sofosbuvir治疗12周的真实经验：先前使用Peginterferon加利巴韦林与HCV NS3 / 4A抑制剂的使用者中获得了持续的病毒学应答
7. PIN102 Impact of Simeprevir Versus Telaprevir Triple Therapy for Chronic Hcv Infection on Patient-Reported Outcomes in Prior Non-Responders to Peginterferon/Ribavirin Results from the Phase Iii Attain Study [O] . Scott J., Corbett C., Gilles L., 2014

机译：PIN102 Simeprevir与特拉帕洛韦三联疗法对慢性Hvv感染的三重治疗对先前对Peginterferon / Ribavirin无效的无反应者的患者报告结果的II期临床研究

Comparative Study between Triple Therapy (Peginterferon /Ribavirin/Sofosbuvir) and Dual Therapy (Simeprevir /Sofosbuvir) in Treatment of Chronic HCV Patients

著录项

引文网络

相似文献

相关主题

期刊订阅